Jazz Pharmaceuticals plc (JAZZ)
NASDAQ: JAZZ · Real-Time Price · USD
229.19
-2.85 (-1.23%)
At close: Jun 9, 2026, 4:00 PM EDT
226.00
-3.19 (-1.39%)
After-hours: Jun 9, 2026, 7:38 PM EDT
Jazz Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 29.45 | -356.15 | 560.12 | 414.83 | -224.06 | -329.67 |
Depreciation & Amortization | 712.9 | 696.3 | 660.07 | 638.7 | 629.47 | 552.48 |
Stock-Based Compensation | 297.93 | 291.13 | 248.05 | 226.84 | 222 | 189.01 |
Other Adjustments | 122.21 | 705.59 | 4.4 | 16.08 | 634.67 | 414.64 |
Change in Receivables | -178.78 | -106.28 | -21.12 | -51.88 | -90.14 | -92.74 |
Changes in Inventories | -128.24 | -86.04 | -45.54 | -13.42 | -49.64 | -48.86 |
Changes in Accounts Payable | -0.65 | 39.85 | -20.07 | 9.6 | -11.23 | 57.02 |
Changes in Accrued Expenses | -111.8 | 77.1 | 86.16 | -23.25 | 165.99 | 142.36 |
Changes in Income Taxes Payable | 61.62 | 37.22 | -14.74 | 25.22 | -1.69 | -15.52 |
Changes in Unearned Revenue | - | - | - | - | -2.09 | -2.31 |
Changes in Other Operating Activities | 82.67 | 57.05 | -61.41 | -150.71 | -1.3 | -87.9 |
Operating Cash Flow | 1,334 | 1,356 | 1,396 | 1,092 | 1,272 | 778.51 |
Operating Cash Flow Growth | -14.39% | -2.88% | 27.83% | -14.15% | 63.39% | -13.46% |
Capital Expenditures | -64.55 | -58.75 | -38.07 | -23.96 | -29.05 | -27.64 |
Purchases of Intangible Assets | -126 | -151 | -10 | -19 | -469.15 | -17.89 |
Proceeds from Sale of Intangible Assets | 122.8 | - | - | - | - | - |
Purchases of Investments | -1,890 | -1,830 | -1,305 | -390.1 | -61.04 | -26.82 |
Proceeds from Sale of Investments | 1,570 | 1,360 | 845 | 270 | 60 | 1,095 |
Payments for Business Acquisitions | -429.03 | -858.05 | - | - | - | -6,235 |
Proceeds from Business Divestments | - | 28.17 | - | - | 53 | - |
Investing Cash Flow | -1,218 | -1,510 | -508.2 | -163.06 | -446.23 | -5,212 |
Long-Term Debt Issued | - | - | 980.77 | - | - | 5,191 |
Long-Term Debt Repaid | -31 | -781 | -606 | -31 | -582.01 | -1,321 |
Net Long-Term Debt Issued (Repaid) | -31 | -781 | 374.77 | -31 | -582.01 | 3,871 |
Issuance of Common Stock | 129.26 | 107.86 | 20.65 | 46.46 | 98.02 | 135.26 |
Repurchase of Common Stock | -62.51 | -125.02 | -311.43 | -269.76 | -0.05 | - |
Net Common Stock Issued (Repurchased) | 66.75 | -17.16 | -290.78 | -223.3 | 97.97 | 135.26 |
Other Financing Activities | -111.62 | -75.22 | -63.47 | -50.95 | -45.44 | -35.6 |
Financing Cash Flow | -138.38 | -873.38 | 20.52 | -305.25 | -529.49 | 3,971 |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | 4.46 | 6.56 | -1.68 | 1.14 | -6.22 | -3.21 |
Net Cash Flow | -17.57 | -1,021 | 906.55 | 624.83 | 290.03 | -466.32 |
Free Cash Flow | 1,270 | 1,297 | 1,358 | 1,068 | 1,243 | 750.87 |
Free Cash Flow Growth | -2.11% | -4.48% | 27.13% | -14.07% | 65.53% | -15.12% |
FCF Margin | 28.60% | 30.39% | 33.37% | 27.86% | 33.97% | 24.27% |
Free Cash Flow Per Share | 20.13 | 21.27 | 20.57 | 14.82 | 19.87 | 12.58 |
Levered Free Cash Flow | 550.43 | -374.43 | 1,501 | 846.01 | -105.61 | 4,111 |
Unlevered Free Cash Flow | 557.06 | 519.17 | 1,422 | 1,274 | 662.82 | 1,066 |